Patents
Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
09/2003
09/24/2003CN1444653A Therapeutic compounds
09/24/2003CN1444652A Mammalian receptor proteins, related regents and methods
09/24/2003CN1444651A Generation of libraries of antibodies in yeast and uses thereof
09/24/2003CN1444602A Human receptor proteins, related reagents and methods
09/24/2003CN1444598A Synthetic immunogenic but non-amyloidogenic peptides homologous to amyloid beta for induction of immune response to amyloid beta and amyloid deposits
09/24/2003CN1443850A Method for preparing recombinant human CTLA4 extracellular region protein, and obtained product and application
09/24/2003CN1443778A Monoclonal antibody of melanic related antigen, and its application and medicine composition
09/24/2003CN1443777A Monoclonal antibody capable of identifying tumor cell surface antigen and its preparation and application
09/24/2003CN1443775A Leptospira outer membrane protein and its code sequence
09/24/2003CN1443773A Leptospira pathogenic related protein and its code squence
09/24/2003CN1122107C Intracellular antifreeze polypeptide and nucleic acids
09/23/2003US6624295 Heavy chain and light chain peptides comprising complement determining regions, including single chain FV fragments, used as thrombolytic agents
09/23/2003US6623981 Detecting antibodies which bind integrin bound modulators; obtain sample, incubate with modulators and antibodies, form complexes, screen for bound complex
09/23/2003US6623980 Mixing polypeptides with exogeneous proteins, oligopeptides, polysaccharides or polynucleotides, then analyzing binding; medical diagnosis and therapy
09/23/2003US6623960 Monoclonal antibodies comprising complementarity determining regions (CDRs) from light chain and heavy chain variable domain peptides used for drug screening; metabolism of xenobiotics and carcinogens
09/23/2003US6623957 Immunotherapy for T-cell mediated autoimmune disease
09/23/2003US6623942 Nucleotide sequences coding polypetide for use in treatment of hematopoietic and immunological disorders; wound healing agents
09/23/2003US6623940 Expression vectors encoding bispecific fusion proteins and methods of producing biologically active bispecific fusion proteins in a mammalian cell
09/23/2003US6623938 Human I-FLICE (Inhibitor of FLICE (FADD-like ICE)) polynucleotides; vectors, host cells and recombinant methods for producing the same
09/23/2003US6623936 Compositions and methods for improved detection and classification of neoplasms
09/23/2003US6623934 For isolation of proteins that may be used to induce bone and/or cartilage or other connective tissue formation, and in wound healing and tissue repair
09/23/2003US6623738 Polypeptide consisting of amino acid sequence 2 or 4 which is not cross reactive with mouse, chick nor drosophila neuro-pilin-1
09/23/2003US6623737 Epitopes; medical diagnosis
09/23/2003US6623736 Interleukin antagonists for the treatment of neurological, retinal and muscular disorders
09/23/2003US6623735 Vaccine containing a thiol protease
09/23/2003CA2164818C Tandem synthetic hiv-1 peptides
09/23/2003CA2139632C Assay for chagas' disease and reagents for its use
09/23/2003CA2139518C Antigenic regions of tlp complexes and antibodies against the same
09/23/2003CA2113099C Differentiation of htlv-i and htlv-ii using synthetic peptides
09/23/2003CA2112907C Peptide which abrogates tnf and/or lps toxicity
09/23/2003CA2082424C Analogs of glycoprotein hormones having altered immunological characteristics, efficacy and/or receptor specificity
09/18/2003WO2003076947A2 Method for monitoring collagen type ii degradation in cartilage
09/18/2003WO2003076946A2 Detection of specific nitrated protein markers
09/18/2003WO2003076934A1 Sandwich assay kits for detecting shigatoxin ctx3c
09/18/2003WO2003076898A2 Mycobacterial diagnostics
09/18/2003WO2003076662A1 Identification of microbial polynucleotides expressed during infection of a host
09/18/2003WO2003076631A2 Genetic products differentially expressed in tumors and use thereof
09/18/2003WO2003076617A1 Transporter selectively transporting sulfate conjugate and its gene
09/18/2003WO2003076610A2 Variants of human kallikrein-2 and kallikrein-3 and uses thereof
09/18/2003WO2003076579A2 Cancer-linked gene as target for chemotherapy
09/18/2003WO2003076571A2 Cancer-linked gene as target for chemotherapy
09/18/2003WO2003076570A2 Antigens and their use as diagnostics and vaccines against species of plasmodium
09/18/2003WO2003076569A2 Novel polypeptides having sequence similarity to gdnfr and nucleic acids encoding the same
09/18/2003WO2003076568A2 Immunotherapeutics for biodefense
09/18/2003WO2003076473A1 Specific ab1'-antibodies against tumour-associated antigen ca 125
09/18/2003WO2003076472A2 Neoplasm specific antibodies and uses thereof
09/18/2003WO2003076471A2 A multifunctional complex for targeting specific phagocytosis of a target agent
09/18/2003WO2003076470A1 Monoclonal and polyclonal antibodies recognizing coagulase-negative staphylococcal proteins
09/18/2003WO2003076469A2 Antibodies derived rom anti ed-b l19 and targeting tumor vasculature
09/18/2003WO2003076465A2 Downregulation of ca 125 tumor antigen and uses thereof
09/18/2003WO2003076455A2 Immunizing composition and method for inducing an immune response against the ss-secretase cleavage site of amyloid precursor protein
09/18/2003WO2003075960A1 Avidin dimers effective in increasing the concentration of radioactive biotin in pretargeted radioimmunotherapy
09/18/2003WO2003075957A1 The prevention or treatment of cancer using integrin alphavbeta3 antagonists in combination with other agents
09/18/2003WO2003075951A2 Novel application of vaccination against tnf-alpha
09/18/2003WO2003075947A1 Use of egfr transactivation inhibitors in human cancer
09/18/2003WO2003075925A1 Methods for reducing body fat and increasing a lean body mass by reducing stearoyl-coa desaturase 1 activity
09/18/2003WO2003075860A2 Detection and modulation of slit and roundabount (robo) mediated angiogenesis and uses thereof
09/18/2003WO2003075855A2 Antibodies against cancer antigen tmeff2 and uses thereof
09/18/2003WO2003075846A2 Uses of monoclonal antibody 8h9
09/18/2003WO2003075845A2 Immunogenicity of glucan binding protein
09/18/2003WO2003075844A2 Compositions and methods for preventing and treating cancer via modulating ube1l, isg15 and/or ubp43
09/18/2003WO2003075841A2 Combination methods of inhibiting tumor growth with a vascular endothelial growth factor receptor antagonist
09/18/2003WO2003075840A2 Human antibodies specific to kdr and uses thereof
09/18/2003WO2003075831A2 NOVEL p53BP2 COMPOUNDS FOR THERAPY AND DIAGNOSIS AND METHODS FOR USING SAME
09/18/2003WO2003075741A2 METHODS OF PREVENTING OR TREATING DISORDERS BY ADMINISTERING AN INTEGRIN αvβ3 ANTAGONIST IN COMBINATION WITH AN HMG-CoA REDUCTASE INHIBITOR OR A BISPHOSPHONATE
09/18/2003WO2003059252A3 Use of a novel cell surface protease from group b streptococcus
09/18/2003WO2003057163A3 Methods for preparing immunoconjugates
09/18/2003WO2003057130A3 Common lymphatic endothelial and vascular endothelial receptor-1 (clever-1) and uses thereof
09/18/2003WO2003027226A3 A method for producing antibody in avian species by intra-muscular injection of coding sequence
09/18/2003WO2003025124A3 Immunoglobulin having particular framework scaffold and methods of making and using
09/18/2003WO2002100901A3 Determination of bone-sialoprotein in bodily fluids for oncological problems
09/18/2003WO2002097079A3 Gene encoding molecular motor protein and diagnosis method for the disease related to the gene
09/18/2003WO2002094868A3 Staphylococcus aureus proteins and nucleic acids
09/18/2003WO2002077267A3 Nucleic acid molecules encoding a transmembran serine protease 9, the encoded polypeptides and methods based thereon
09/18/2003WO2002077174A3 Human cytokine receptor
09/18/2003WO2002072790A3 Tsg101-gag interaction and use thereof
09/18/2003WO2002066646A3 Neurotransmission-associated proteins
09/18/2003WO2002059308A3 Method of diagnosing and treating cartilage disorders
09/18/2003WO2002053177A3 Agents and methods for treating pain
09/18/2003WO2002036625A9 Prokineticin polypeptides, related compositions and methods
09/18/2003WO2002031181A3 Flea synaptic vesicle nucleic acid molecules, proteins and uses thereof
09/18/2003US20030177511 Antitumor, anticancer agents
09/18/2003US20030176689 Inhibitors of hepatitis C virus protease
09/18/2003US20030176688 Expression systems utilizing autolyzing fusion proteins and a novel reducing polypeptide
09/18/2003US20030176686 Diagnosis, therapy; animal growth regulators; controlling cell differentiation; antiiinflammatory agents, antihistamines, Crohn's disease, anticancer agents, autoimmune disease
09/18/2003US20030176684 Secreted and transmembrane polypeptides and nucleic acids encoding the same
09/18/2003US20030176679 Polynucleotides and their use for detecting resistance to streptogramin A or to streptogramin B and related compounds
09/18/2003US20030176678 Viricides, antitumor agents, antiproliferative agents, anticancer agents; genetic engineered Dna
09/18/2003US20030176676 Methods of treating vascular inflammatory pathologies using chimeric anti-TNF antibodies
09/18/2003US20030176674 Vascular endothelial growth factor 2
09/18/2003US20030176666 Hypothalamus-specific polypeptides
09/18/2003US20030176664 Use of anti-tissue factor antibodies for treating thromboses
09/18/2003US20030176663 Specific binding molecules for scintigraphy
09/18/2003US20030176661 Novel antibody with specificity for colon cancer
09/18/2003US20030176660 Avian transgenic antibodies; chromatography
09/18/2003US20030176650 Nucleic acids, polypeptides, single nucleotide polymorphisms and methods of use thereof
09/18/2003US20030176648 Ion channel
09/18/2003US20030176647 Antibodies to OCIF-binding molecules
09/18/2003US20030176349 Stable hypoxia inducible factor-1 alpha and method of use
09/18/2003US20030176348 For use as therapeutic agent for a syndrome resembling premature aging, a therapeutic agent for adult diseases or an aging-suppressing agent